skip to main content
Immunologi
Våre andre terapiområder

    • {%buzitemName%}
        {%buzbrandMenuItems%}
    • {%bitemName%} {%barrowSpan%}
        {%bsubBrandMenuItems%}
    • {%sbitemName%} {%sbarrowSpan%}
        {%sbproductMenuItems%}
    • {%pitemKeyName%} {%pitemBadges%} {%parrowSpan%}
      {%pselfProduct%}
    • {%mNavitemName%}
      • {%lScountries%}
    • {%allMenuItem%}
      • {%cSlanguages%}

      • Immunologi

      Reumatologi
      RINVOQ (upadacitinib) RA
      RINVOQ (upadacitinib) axSpA
      RINVOQ (upadacitinib) PsA
      Dermatologi
      RINVOQ (upadacitinib) AD
      SKYRIZI (risankizumab) PsO/PsA
      Gastroenterologi
      IBD
      RINVOQ (upadacitinib) UC/CD
      SKYRIZI (risankizumab) CD
      HUMIRA (adalimumab)

      NO-IMM-230008v2.0 Okt.2023